The effect of Epstein–Barr virus viremia on the progression to severe COVID-19

Epstein–Barr virus (EBV) is frequently reactivated by coronavirus 2019 (COVID-19), and a high incidence of EBV viremia has been reported in patients with severe COVID-19. However, the impact of EBV viremia on progression to severe COVID-19 is unclear. Therefore, we conducted a study to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Im, Jae Hyoung, Nahm, Chung Hyun, Je, Young Soo, Lee, Jin-Soo, Baek, Ji Hyeon, Kwon, Hea Yoon, Chung, Moon-Hyun, Jang, Ji-Hun, Kim, Jung Soo, Lim, Jun Hyeok, Park, Mi Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276369/
https://www.ncbi.nlm.nih.gov/pubmed/35550458
http://dx.doi.org/10.1097/MD.0000000000029027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276369/
https://www.ncbi.nlm.nih.gov/pubmed/35550458
http://dx.doi.org/10.1097/MD.0000000000029027

Ejemplares similares